A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)

NCT03951753 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Tirzepatide
DRUG: Semaglutide
DRUG: Placebo

Sponsor

Eli Lilly and Company